» Articles » PMID: 37903118

Prevalence of Carbapenem-resistant and Extended-spectrum Beta-lactamase-producing Enterobacteriaceae in a Teaching Hospital in Ghana

Overview
Journal PLoS One
Date 2023 Oct 30
PMID 37903118
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Carbapenem-resistant Enterobacteriaceae (CRE) and Extended-spectrum beta-lactamase (ESBL) production among Gram-negative Enterobacteriaceae is an increasing global challenge due to the high morbidity and mortality associated with their infections, especially in developing countries where there are little antibiotic treatment options. Despite these challenges, few studies in Ghana have described the burden of CRE. Therefore, this study aimed to determine the prevalence of carbapenem-resistant Enterobacteriaceae isolated from patients at the Cape Coast Teaching Hospital (CCTH) in the Central region of Ghana.

Methodology/principal Findings: Enterobacteriaceae isolates were collected from April to July 2019 at the bacteriology unit of CCTH using a consecutive sampling method. Isolates were identified by standard microbiological techniques and confirmed using API 20E. Kirby Bauer disc diffusion method was used to determine the antibiogram of isolates. Isolates were also subjected to ESBL testing using the single-disc combination method. Carbapenem-resistant isolates were identified by the Kirby Bauer disc diffusion method and then examined genotypically for the presence of blaKPC-1, blaIMP-1, blaVIM-1, blaNDM-1, and blaOXA-48 genes via polymerase chain reaction (PCR). Of the 230 isolates comprising E. coli (40.9%), Citrobacter spp. (32.6%), K. pneumoniae (9.1%), P. mirabilis (6.1%), P. vulgaris (5.2%), Enterobacter spp (3.5%)., K. oxytoca (2.2%), and Serratia marcenses (0.4%). Most isolates were from urine 162(70.4%) and wound samples. The isolates showed high resistance to ampicillin 171 (74.3%) and cefuroxime 134(58.3%). The prevalence of MDR was 35.2% (81), with E. coli 40(42.6%) being the majority that exhibited MDR. Of the 230 isolates, 113(49.1%) were ESBL producers, with E. coli 54(57.5%) accounting for the majority, while Serratia marcenses was the least. Of the 13 (5.7%) CRE isolates that showed resistance towards carbapenem in the disc diffusion method, 11 showed the presence of the blaNDM-1 gene, while all isolates showed the presence of the blaOXA-48 gene.

Conclusion: The prevalence of carbapenem resistance and ESBL-producing Enterobacteriaceae pathogens among patients at the Cape Coast Teaching Hospital is high and alarming. Therefore, it is imperative to consider effective infection prevention and control measures should be implemented at the hospital to prevent the rapid spread of these dangerous organisms.

Citing Articles

A systematic review and meta-analysis on antibiotic resistance genes in Ghana.

Donkor E, Odoom A, Osman A, Darkwah S, Kotey F BMC Med Genomics. 2025; 18(1):47.

PMID: 40075357 PMC: 11899156. DOI: 10.1186/s12920-024-02050-y.


Unveiling the potential of spirulina algal extract as promising antibacterial and antibiofilm agent against carbapenem-resistant Klebsiella pneumoniae: in vitro and in vivo study.

Selim M, El-Banna T, Sonbol F, Negm W, Elekhnawy E Microb Cell Fact. 2025; 24(1):7.

PMID: 39755644 PMC: 11700449. DOI: 10.1186/s12934-024-02619-3.


A systematic review and meta-analysis of carbapenem-resistant Enterobacteriaceae in West Africa.

Somda N, Nyarkoh R, Kotey F, Tetteh-Quarcoo P, Donkor E BMC Med Genomics. 2024; 17(1):267.

PMID: 39533268 PMC: 11555847. DOI: 10.1186/s12920-024-02043-x.


Antimicrobial Resistance in the WHO African Region: A Systematic Literature Review 2016-2020.

Gahimbare L, Muvunyi C, Guessennd N, Rutanga J, Gashema P, Fuller W Antibiotics (Basel). 2024; 13(7).

PMID: 39061341 PMC: 11273377. DOI: 10.3390/antibiotics13070659.

References
1.
Tada T, Miyoshi-Akiyama T, Dahal R, Mishra S, Ohara H, Shimada K . Dissemination of multidrug-resistant Klebsiella pneumoniae clinical isolates with various combinations of carbapenemases (NDM-1 and OXA-72) and 16S rRNA methylases (ArmA, RmtC and RmtF) in Nepal. Int J Antimicrob Agents. 2013; 42(4):372-4. DOI: 10.1016/j.ijantimicag.2013.06.014. View

2.
Qin S, Fu Y, Zhang Q, Qi H, Wen J, Xu H . High incidence and endemic spread of NDM-1-positive Enterobacteriaceae in Henan Province, China. Antimicrob Agents Chemother. 2014; 58(8):4275-82. PMC: 4136005. DOI: 10.1128/AAC.02813-13. View

3.
Nordmann P, Naas T, Poirel L . Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011; 17(10):1791-8. PMC: 3310682. DOI: 10.3201/eid1710.110655. View

4.
Ehrhard I, Karaalp A, Hackel T, Holl G, Rodewald N, Reif U . [Prevalence of carbapenemase-producing bacteria in hospitals in Saxony, Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014; 57(4):406-13. DOI: 10.1007/s00103-013-1914-z. View

5.
Ouedraogo A, Sanou M, Kissou A, Sanou S, Solare H, Kabore F . High prevalence of extended-spectrum ß-lactamase producing enterobacteriaceae among clinical isolates in Burkina Faso. BMC Infect Dis. 2016; 16:326. PMC: 4939587. DOI: 10.1186/s12879-016-1655-3. View